Tokyo Tape
Sign in
← CellSeed

Quarterly report · Q1

7776.TEDINET S100QQQQ
Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
MetricValuePeriodScopeSource row
Revenue¥31m2023-01-01 → 2023-03-31StandaloneNet sales
Revenue¥126m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥38m2022-01-01 → 2022-03-31StandaloneNet sales
Operating income−¥182m2023-01-01 → 2023-03-31StandaloneOperating income
Operating income−¥192m2022-01-01 → 2022-03-31StandaloneOperating income
Ordinary income−¥184m2023-01-01 → 2023-03-31StandaloneOrdinary income
Ordinary income−¥754m2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥196m2022-01-01 → 2022-03-31StandaloneOrdinary income
Profit before tax−¥184m2023-01-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax−¥198m2022-01-01 → 2022-03-31StandaloneIncome before income taxes
Net income−¥184m2023-01-01 → 2023-03-31StandaloneProfit loss
Net income−¥760m2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income−¥199m2022-01-01 → 2022-03-31StandaloneProfit loss
Total assets¥2.0bnat 2023-03-31StandaloneAssets
Total assets¥1.5bnat 2022-12-31StandaloneAssets
Total assets¥1.4bnat 2022-03-31StandaloneTotal assets (5-year summary)
Total liabilities¥399mat 2023-03-31StandaloneLiabilities
Total liabilities¥366mat 2022-12-31StandaloneLiabilities
Net assets / equity¥1.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥946mat 2022-03-31StandaloneNet assets (5-year summary)
Cash and deposits¥1.6bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥1.1bnat 2022-12-31StandaloneCash and deposits
EPS (basic)¥-6.812023-01-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-10.982022-01-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio79.2%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio66.6%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Shares issued27,659,419at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued24,422,619at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued18,468,119at 2022-03-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥54m
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2023-01-01 → 2023-03-31¥249,000
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2023-01-01 → 2023-03-31¥249,000
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2023-01-01 → 2023-03-31−¥115m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2023-01-01 → 2023-03-31¥30m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2023-01-01 → 2023-03-31¥30m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2023-01-01 → 2023-03-31−¥13m
—segment totalrevenue2023-01-01 → 2023-03-31¥31m
—segment totalrevenue external2023-01-01 → 2023-03-31¥31m
—segment totalsegment profit2023-01-01 → 2023-03-31−¥128m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥55m
jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2022-01-01 → 2022-03-31−¥116m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2022-01-01 → 2022-03-31¥38m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2022-01-01 → 2022-03-31¥38m
jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2022-01-01 → 2022-03-31−¥21m
—segment totalrevenue2022-01-01 → 2022-03-31¥38m
—segment totalrevenue external2022-01-01 → 2022-03-31¥38m
—segment totalsegment profit2022-01-01 → 2022-03-31−¥137m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 305
ItemContextValueUnit
Notes revenue recognition quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly financial statements (text)CurrentYTDDurationText · Plus
Other information financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass